The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Rapydan 70 mg/70 mg medicated plaster

Eurocept International BVPA1591/001/001

Main Information

Trade NameRapydan 70 mg/70 mg medicated plaster
Active SubstancesLidocaine
Dosage FormMedicated plaster
Licence HolderEurocept International BV
Licence NumberPA1591/001/001

Group Information

ATC CodeN01BB Amides
N01BB52 lidocaine, combinations


License statusAuthorised
Licence Issued25/01/2008
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back